PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.35
Similar ESG score to SGMO's 59.37. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
57.07
Environmental score 1.1-1.2x SGMO's 54.13. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
60.74
Social score 90-95% of SGMO's 65.66. Bill Ackman would demand clear social improvement catalysts.
63.25
Governance score 1.1-1.2x SGMO's 58.31. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.